- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Pregnancy Can Delay MS Onset by 3 Years, Study Says
The researchers noted that although it is known that pregnancy is linked to reduced MS activity, the effect of pregnancy before MS diagnosis is unclear.
A recent global study found that pregnancy can delay the onset of multiple sclerosis (MS) by more than 3 years.
The study looked at 2557 women who were patients in Australia and the Czech Republic with clinically isolated syndrome, a subset of MS.
MS is most often diagnosed in women of childbearing years. Pregnancy could reduce the abnormal over-activity of the immune system that causes MS, potentially long term, said the authors, writing in JAMA Neurology.
Researchers collected data on gravida, defined as any pregnancy, whether live or spontaneous miscarriage or termination, and parity, defined as childbirth after gestational age of more than 10 weeks, including livebirth and stillbirth.
Of these women, 1188 (46%) had at least 1 pregnancy and 1100 (43%) had at least 1 childbirth. Investigators found that later-onset CIS was more common in women with previous pregnancies and childbirths compared to those who had never been pregnant (HR, 0.68; 95% CI, 0.62–0.75; P <.001), with a median delay of 3.3 years (95% CI, 2.5–4.1).
A similar delay in MS onset was also observed in women who had delivered at term, with onset delayed, on average, by 3.4 years.
Of the 2557 women, 71 (3%) had their first MS symptom during pregnancy.
Having 1 (HR, 0.70; 95% CI 0.61–0.79), 2 (HR, 0.67; 95% CI, 0.60–0.76), or 3 or more pregnancies (HR, 0.66; 95% CI, 0.58–0.75) delayed the onset of CIS compared with no pregnancies (P <.001).
A higher number of pregnancies and childbirths was not associated with later CIS onset.
The researchers noted that although it is known that pregnancy is linked to reduced MS activity, the effect of pregnancy before MS diagnosis is unclear.
Investigators noted that further studies are needed to help explain the mechanisms behind the associations between pregnancy and onset of MS.
Reference
Nguyen A, Vodehnalova K, Klinicik T, et al. Association of pregnancy with the onset of clinically isolated syndrome. JAMA Neurol. Published online September 14, 2020. doi: 10.1001/jamaneurol.2020.3324.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
FDA Issues CRL for Glatiramer Acetate Depot for Relapsing Forms of MS
March 11th 2024The FDA has declined to approve glatiramer acetate (GA) depot in the treatment of relapsing types of multiple sclerosis (MS), issuing a complete response letter (CRL) for the long-acting, injectable form of GA.
Read More
Choroid Plexus Indicated in MS Pathology
February 9th 2024A longitudinal, observational study found that the choroid plexus, a network of blood vessels in each ventricle of the brain, plays a potential role in the neurodegenerative and chronic inflammatory process experienced by patients with relapsing remitting multiple sclerosis (MS).
Read More
